Increased levels of serum amyloid A during the early phase of hepatitis C treatment with interferon are associated with sustained virologic response - a pilot study

J Gastrointestin Liver Dis. 2014 Mar;23(1):101-2.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Biomarkers / blood
  • Drug Monitoring / methods
  • Drug Therapy, Combination
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferons / therapeutic use*
  • Male
  • Middle Aged
  • Pilot Projects
  • Prognosis
  • Ribavirin / therapeutic use
  • Serum Amyloid A Protein / metabolism*
  • Treatment Outcome
  • Young Adult

Substances

  • Antiviral Agents
  • Biomarkers
  • Serum Amyloid A Protein
  • Ribavirin
  • Interferons